Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. Mar 15, 2025; 17(3): 102187
Published online Mar 15, 2025. doi: 10.4251/wjgo.v17.i3.102187
Published online Mar 15, 2025. doi: 10.4251/wjgo.v17.i3.102187
Figure 8 Clonogenic assays of HepG2 and Huh7 cells treated with different concentrations of tetrahydrocurcumin.
A: Representative images of colony formation under different treatment concentration (25, 50, and 100 μmol/L); B: Quantification of colony formation under all conditions for the two cell lines. All data are presented as mean ± SD, n = 3. aP < 0.05 vs the control group. THC: Tetrahydrocurcumin.
- Citation: Bao ZC, Liu ZD, Zhang Y, Dai HJ, Jia H, Ren F, Li N, Zhao L, Wang YW, Lv SY, Zhang Y. To investigate the effect and mechanism of tetrahydrocurcumin on hepatocellular carcinoma based on phosphoinositide 3-kinases/AKT signaling pathway. World J Gastrointest Oncol 2025; 17(3): 102187
- URL: https://www.wjgnet.com/1948-5204/full/v17/i3/102187.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i3.102187